AGTC to Present at Phacilitate Cell & Gene Therapy World 2017
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Jan. 12, 2017 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the …